{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:17:17Z","timestamp":1789906637349,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jns.2025.125716","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T16:08:19Z","timestamp":1767802099000},"page":"125716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Impact of corticosteroid use on comorbidities in patients with myasthenia gravis in the US National Veterans Affairs Health Network"],"prefix":"10.1016","volume":"481","author":[{"given":"Cynthia Z.","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuebing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuan","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Gelinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis A.","family":"Lizarraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Blein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke","family":"De Ruyck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jns.2025.125716_bb0005","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/mus.28006","article-title":"Incidence and prevalence of myasthenia gravis in the United States: a claims-based analysis","volume":"69","author":"Rodrigues","year":"2024","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.jns.2025.125716_bb0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.25122\/jml-2020-0145","article-title":"The epidemiology of myasthenia gravis","volume":"14","author":"Bubuioc","year":"2021","journal-title":"J. Med. Life"},{"key":"10.1016\/j.jns.2025.125716_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1339167","article-title":"Epidemiology of myasthenia gravis in the United States","volume":"15","author":"Ye","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2025.125716_bb0020","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3389\/fneur.2020.00604","article-title":"A practical approach to managing patients with myasthenia gravis-opinions and a review of the literature","volume":"11","author":"Farrugia","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2025.125716_bb0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ajo.2019.04.017","article-title":"Incidence, epidemiology, and transformation of ocular myasthenia gravis: a population-based study","volume":"205","author":"Hendricks","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.jns.2025.125716_bb0030","article-title":"Tracking myasthenia gravis severity over time: insights from the French health insurance claims database","author":"Attarian","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2025.125716_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2024.123322","article-title":"Characteristics and healthcare utilization of patients with myasthenia gravis exacerbation","volume":"468","author":"Qi","year":"2025","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2025.125716_bb0040","doi-asserted-by":"crossref","DOI":"10.1177\/17562864221150327","article-title":"Healthcare resource use in myasthenia gravis: a US health claims analysis","volume":"16","author":"Mahic","year":"2023","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"4","key":"10.1016\/j.jns.2025.125716_bb0045","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.nmd.2023.02.002","article-title":"Epidemiology and treatment of myasthenia gravis: a retrospective study using a large insurance claims dataset in Germany","volume":"33","author":"Mevius","year":"2023","journal-title":"Neuromuscul. Disord."},{"issue":"1","key":"10.1016\/j.jns.2025.125716_bb0050","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12883-022-02692-4","article-title":"A retrospective longitudinal cohort study of the clinical burden in myasthenia gravis","volume":"22","author":"Harris","year":"2022","journal-title":"BMC Neurol."},{"issue":"6","key":"10.1016\/j.jns.2025.125716_bb0055","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1007\/s00415-021-10891-1","article-title":"Burden of disease in myasthenia gravis: taking the patient\u2019s perspective","volume":"269","author":"Lehnerer","year":"2022","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2025.125716_bb0060","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1007\/s00415-021-10759-4","article-title":"Long-term outcome in patients with myasthenia gravis: one decade longitudinal study","volume":"269","author":"Bozovic","year":"2022","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2025.125716_bb0065","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s13023-023-02727-0","article-title":"Physician- and patient-reported perspectives on myasthenia gravis in Europe: a real-world survey","volume":"18","author":"Mahic","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.jns.2025.125716_bb0070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s13760-019-01102-w","article-title":"A study of comorbidities in myasthenia gravis","volume":"120","author":"Misra","year":"2020","journal-title":"Acta Neurol. Belg."},{"issue":"17_supplement_2","key":"10.1016\/j.jns.2025.125716_bb0075","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000202377","article-title":"Comorbidities in patients with myasthenia gravis in the USA: a retrospective claims database analysis (P1-5.003)","volume":"100","author":"Basoff","year":"2023","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jns.2025.125716_bb0080","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4172\/2155-9562.1000317","article-title":"Myasthenia gravis and its comorbidities","volume":"6","author":"Cacho Diaz","year":"2015","journal-title":"J. Neurol. Neurophysiol."},{"issue":"7","key":"10.1016\/j.jns.2025.125716_bb0085","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1007\/s10072-024-07368-0","article-title":"Comorbidity in myasthenia gravis: multicentric, hospital-based, and controlled study of 178 Italian patients","volume":"45","author":"Di Stefano","year":"2024","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jns.2025.125716_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117549","article-title":"Comorbidities worsen the prognosis of generalized myasthenia gravis post-thymectomy","volume":"427","author":"Laakso","year":"2021","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.jns.2025.125716_bb0095","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12974-022-02448-4","article-title":"Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients","volume":"19","author":"Nelke","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.jns.2025.125716_bb0100","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/ane.13549","article-title":"Comorbidities in older patients with myasthenia gravis - comparison between early- and late-onset disease","volume":"145","author":"Klimiec-Moskal","year":"2022","journal-title":"Acta Neurol. Scand."},{"issue":"7","key":"10.1016\/j.jns.2025.125716_bb0105","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/ene.12439","article-title":"Total drug treatment and comorbidity in myasthenia gravis: a population-based cohort study","volume":"21","author":"Andersen","year":"2014","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2025.125716_bb0110","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1212\/WNL.0000000000011124","article-title":"International consensus guidance for Management of Myasthenia Gravis: 2020 update","volume":"96","author":"Narayanaswami","year":"2021","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jns.2025.125716_bb0115","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis: executive summary","volume":"87","author":"Sanders","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jns.2025.125716_bb0120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/mus.27791","article-title":"Treatment patterns in myasthenia gravis: a United States health claims analysis","volume":"67","author":"Mahic","year":"2023","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.jns.2025.125716_bb0125","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.neurol.2023.09.004","article-title":"Epidemiology of myasthenia gravis in France: a retrospective claims database study (STAMINA)","volume":"180","author":"Salort-Campana","year":"2024","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.jns.2025.125716_bb0130","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3389\/fneur.2020.00981","article-title":"From traditional to targeted immunotherapy in myasthenia gravis: prospects for research","volume":"11","author":"Mantegazza","year":"2020","journal-title":"Front. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2025.125716_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e16367","article-title":"Real world study on prevalence, treatment and economic burden of myasthenia gravis in Italy","volume":"9","author":"Antonini","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.jns.2025.125716_bb0140","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.2147\/NDT.S296714","article-title":"Myasthenia gravis and Lambert-Eaton myasthenic syndrome: new developments in diagnosis and treatment","volume":"18","author":"Pascuzzi","year":"2022","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"6","key":"10.1016\/j.jns.2025.125716_bb0145","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/mus.27526","article-title":"Validation of myasthenia gravis diagnosis in the older Medicare population","volume":"65","author":"Lee","year":"2022","journal-title":"Muscle Nerve"},{"issue":"10","key":"10.1016\/j.jns.2025.125716_bb0150","first-page":"1","article-title":"Deaths: leading causes for 2022","volume":"73","author":"Curtin","year":"2024","journal-title":"Natl. Vital Stat. Rep."},{"key":"10.1016\/j.jns.2025.125716_bb0155","article-title":"Myasthenia gravis outcomes after use of statins and other contraindicated treatments: results from the French national insurance database","author":"Sole","year":"2025","journal-title":"Eur. J. Neurol."},{"issue":"12","key":"10.1016\/j.jns.2025.125716_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14124221","article-title":"Risk of diabetes mellitus in the myasthenia gravis: a systematic review and meta-analysis","volume":"14","author":"Giannopapas","year":"2025","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.jns.2025.125716_bb0165","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s13300-023-01393-6","article-title":"Practical guide to glucocorticoid induced hyperglycaemia and diabetes","volume":"14","author":"Barker","year":"2023","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.jns.2025.125716_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2024.123314","article-title":"Aging and infectious diseases in myasthenia gravis","volume":"468","author":"Bril","year":"2025","journal-title":"J. Neurol. Sci."},{"issue":"7_supplement_1","key":"10.1016\/j.jns.2025.125716_bb0175","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000206555","article-title":"Analysis of serious infections and malignancy risk in myasthenia gravis: a US claims database study (P10\u201311.007)","volume":"102","author":"Podhorna","year":"2024","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.jns.2025.125716_bb0180","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1212\/WNL.0000000000000804","article-title":"Increased risk of osteoporosis in patients with myasthenia gravis: a population-based cohort study","volume":"83","author":"Yeh","year":"2014","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jns.2025.125716_bb0185","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/jbmr\/zjae043","article-title":"Risk of fracture in patients with myasthenia gravis: a nationwide cohort study in Korea","volume":"39","author":"Park","year":"2024","journal-title":"J. Bone Miner. Res."},{"issue":"10","key":"10.1016\/j.jns.2025.125716_bb0190","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s00198-024-07097-2","article-title":"The association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis","volume":"35","author":"Lin","year":"2024","journal-title":"Osteoporos. Int."},{"issue":"104441","key":"10.1016\/j.jns.2025.125716_bb0195","first-page":"128","article-title":"Cardiovascular comorbidities in myasthenia gravis: a systematic review and meta-analysis","volume":"43","author":"Tahir","year":"2024","journal-title":"Neuromuscul. Disord."},{"issue":"6","key":"10.1016\/j.jns.2025.125716_bb0200","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2165\/00002512-199915060-00004","article-title":"Corticosteroids and glaucoma risk","volume":"15","author":"Tripathi","year":"1999","journal-title":"Drugs Aging"},{"issue":"1","key":"10.1016\/j.jns.2025.125716_bb0205","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12883-020-01802-4","article-title":"Prospective study of stress, depression and personality in myasthenia gravis relapses","volume":"20","author":"Bogdan","year":"2020","journal-title":"BMC Neurol."},{"issue":"1","key":"10.1016\/j.jns.2025.125716_bb0210","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22078-3","article-title":"Mental health in myasthenia gravis patients and its impact on caregiver burden","volume":"12","author":"Marbin","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jns.2025.125716_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2840","article-title":"Prevalence of depression and anxiety among myasthenia gravis (MG) patients: a systematic review and meta-analysis","volume":"13","author":"Nadali","year":"2023","journal-title":"Brain Behav."},{"issue":"7_supplement_1","key":"10.1016\/j.jns.2025.125716_bb0220","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000205871","article-title":"Real-world reduction in oral corticosteroid utilization following efgartigimod initiation in patients living with generalized myasthenia gravis (S38.002)","volume":"102","author":"Goyal","year":"2024","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jns.2025.125716_bb0225","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00415-025-13127-8","article-title":"Ravulizumab for generalized myasthenia gravis: a multicenter real-life experience","volume":"272","author":"Rossini","year":"2025","journal-title":"J. Neurol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X2502338X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X2502338X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T14:23:16Z","timestamp":1774275796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X2502338X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":45,"alternative-id":["S0022510X2502338X"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2025.125716","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of corticosteroid use on comorbidities in patients with myasthenia gravis in the US National Veterans Affairs Health Network","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2025.125716","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"125716"}}